D. E. Shaw & Co., Inc. Dynavax Technologies Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,431,359 shares of DVAX stock, worth $18.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,431,359

Holding current value

$18.6 Million

% of portfolio

0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $11.61 $5.93 Million - $6.86 Million	590,476 Added 70.22%	1,431,359 $15.9 Million
Q2 2024 Aug 14, 2024	BUY	$10.73 - $12.58 $5.35 Million - $6.28 Million	498,845 Added 145.84%	840,883 $9.44 Million
Q1 2024 May 15, 2024	SELL	$11.7 - $14.98 $1.97 Million - $2.52 Million	-168,219 Reduced 32.97%	342,038 $4.24 Million
Q4 2023 Feb 14, 2024	SELL	$13.09 - $14.98 $4.05 Million - $4.63 Million	-309,353 Reduced 37.74%	510,257 $7.13 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $214,766 - $254,695	16,991 Added 2.12%	819,610 $12.1 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.17 $2.33 Million - $3.12 Million	236,727 Added 41.83%	802,619 $10.4 Million
Q1 2023 May 15, 2023	SELL	$9.44 - $11.88 $543,602 - $684,109	-57,585 Reduced 9.24%	565,892 $5.55 Million
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $1.79 Million - $2.32 Million	174,351 Added 38.82%	623,477 $6.63 Million
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $1.93 Million - $3.39 Million	-194,282 Reduced 30.2%	449,126 $4.69 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $5.65 Million - $9.74 Million	-758,993 Reduced 54.12%	643,408 $8.1 Million
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $6.62 Million - $9.81 Million	-679,311 Reduced 32.63%	1,402,401 $15.2 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $739,693 - $1.18 Million	56,165 Added 2.77%	2,081,712 $29.3 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $9.65 Million - $20.9 Million	1,053,737 Added 108.43%	2,025,547 $38.9 Million
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $4.02 Million - $6.09 Million	554,266 Added 132.74%	971,810 $9.57 Million
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $1.86 Million - $4.55 Million	407,244 Added 3953.83%	417,544 $4.1 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $35,606 - $53,457	-9,546 Reduced 48.1%	10,300 $46,000
Q3 2020 Nov 16, 2020	SELL	$4.32 - $11.7 $1.63 Million - $4.41 Million	-377,318 Reduced 95.0%	19,846 $86,000
Q2 2020 Aug 14, 2020	SELL	$2.94 - $9.1 $3.69 Million - $11.4 Million	-1,255,712 Reduced 75.97%	397,164 $3.52 Million
Q1 2020 May 15, 2020	BUY	$2.27 - $6.2 $1.32 Million - $3.6 Million	580,564 Added 54.14%	1,652,876 $5.83 Million
Q4 2019 Feb 14, 2020	SELL	$3.46 - $6.93 $142,673 - $285,758	-41,235 Reduced 3.7%	1,072,312 $6.13 Million
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $1.75 Million - $3.16 Million	-650,880 Reduced 36.89%	1,113,547 $3.98 Million
Q2 2019 Aug 14, 2019	SELL	$3.65 - $7.89 $2.05 Million - $4.44 Million	-562,285 Reduced 24.17%	1,764,427 $7.04 Million
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $227,919 - $389,201	32,192 Added 1.4%	2,326,712 $17 Million
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $1.57 Million - $2.56 Million	192,770 Added 9.17%	2,294,520 $21 Million
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $3.49 Million - $4.72 Million	294,790 Added 16.31%	2,101,750 $26.1 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $2.43 Million - $3.33 Million	160,677 Added 9.76%	1,806,960 $27.6 Million
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $161,281 - $219,079	-11,009 Reduced 0.66%	1,646,283 $32.7 Million
Q4 2017 Feb 14, 2018	SELL	$17.3 - $24.08 $10.3 Million - $14.4 Million	-597,802 Reduced 26.51%	1,657,292 $31 Million
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $34.3 Million - $48.5 Million	2,255,094	2,255,094 $48.5 Million

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.64B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account